BetterScholar BetterScholar

M. Lacouture

Annals of Oncology, Journal of Immunotherapy for Cancer, Nature Reviews. Cancer, Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, Supportive Care in Cancer, Cancer Discovery, European Journal of Cancer, The Oncologist Show more
12
Role
Title
Level Year L/R
🐜 Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
81 auth. I. Puzanov, A. Diab, K. Abdallah, C. Bingham, C. Brogdon, R. Dadu, L. Hamad, S. Kim, M. Lacouture, N. LeBoeuf, D. Lenihan, C. Onofrei, V. Shannon, R. Sharma, A. Silk, ... D. Skondra, M. Suarez‐Almazor, Y. Wang, K. Wiley, H. Kaufman, M. Ernstoff, J. Anderson, Deborah Arrindell, S. Andrews, J. Ballesteros, J. Boyer, Daniel S Chen, David Chonzi, I. Cotarla, R. Cunha, M. Davies, M. Dawson, A. Dicker, L. Eifler, Andrew D. Ferguson, C. Ferlini, S. Frankel, W. Go, Celestine G. Gochett, J. Goldberg, P. Goncalves, T. Goswami, Nancy C. Gregory, J. Gulley, V. Hayreh, Nicole Helie, William C. Holmes, J. hsu, R. Ibrahim, C. Larocca, K. Lehman, S. Ley-Acosta, O. Lambotte, J. Luke, J. Mcclure, E. Michelon, Mary C. Nakamura, K. Patel, B. Piperdi, Z. Rasheed, D. Reshef, J. Riemer, C. Robert, M. Sarkeshik, Ann Saylors, J. Schreiber, K. Shafer-Weaver, W. Sharfman, E. Sharon, R. Sherry, C. Simonson, C. Thomas, John A Thompson, E. Trehu, D. Tresnan, M. Turner, Darshan Wariabharaj, I. Waxman, L. Wood, Lin Zhang, P. Zheng 		10 2017
10
🐜
🐜 Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.
11 auth. J. Naidoo, D. Page, Bob T. Li, L. Connell, K. Schindler, M. Lacouture, ... M. Lacouture, M. Postow, M. Postow, J. Wolchok, J. Wolchok 		9 2015
9
🐜
🐜 Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.
11 auth. J. Naidoo, D. Page, Bob T. Li, L. Connell, K. Schindler, M. Lacouture, ... M. Lacouture, M. Postow, M. Postow, J. Wolchok, J. Wolchok 		9 2015
9
🐜
🦁 Mechanisms of cutaneous toxicities to EGFR inhibitors
M. Lacouture 		9 2006
9
🦁
🐜 Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.
8 auth. J. Naidoo, D. Page, B. Li, L. Connell, K. Schindler, M. Lacouture, ... M. Postow, J. Wolchok 		9 2016
9
🐜
🐜 Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
23 auth. J. Brahmer, Hamzah Abu-Sbeih, P. Ascierto, J. Brufsky, L. Cappelli, Frank B. Cortazar, D. Gerber, L. Hamad, Eric D. Hansen, Douglas B. Johnson, ... M. Lacouture, G. Masters, J. Naidoo, M. Nanni, M. Perales, I. Puzanov, B. Santomasso, S. Shanbhag, Rajeev Sharma, D. Skondra, J. Sosman, M. Turner, M. Ernstoff 		8 2021
8
🐜
🦁 Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer.
8 auth. M. Lacouture, E. Mitchell, B. Piperdi, M. Pillai, H. Shearer, N. Iannotti, ... Feng Xu, M. Yassine 		8 2010
8
🦁
🐜 NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Management of Immunotherapy- Related Toxicities, Version 1.2019
31 auth. John A Thompson, B. Schneider, J. Brahmer, S. Andrews, Philippe Armand, S. Bhatia, L. Budde, Luciano Costa, M. Davies, D. Dunnington, M. Ernstoff, M. Frigault, Brianna W. Hoffner, C. Hoimes, M. Lacouture, ... Frederick Locke, M. Lunning, N. Mohindra, J. Naidoo, A. Olszanski, O. Oluwole, S. Patel, S. Reddy, Mabel Ryder, B. Santomasso, S. Shofer, J. Sosman, M. Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone 		8 2019
8
🐜
🦁 Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
8 auth. M. Lacouture, M. Anadkat, R. Bensadoun, J. Bryce, A. Chan, J. Epstein, ... B. Eaby-Sandy, B. Murphy 		8 2011
8
🦁
🐜 Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.
48 auth. E. Diamond, B. Durham, J. Haroche, Z. Yao, Jing Ma, S. Parikh, Zhaoming Wang, J. Choi, Eunhee Kim, F. Cohen-Aubart, Stanley C. Lee, Yijun Gao, J. Micol, Patrick K. Campbell, M. Walsh, ... B. Sylvester, Igor Dolgalev, Olga S. Aminova, A. Heguy, Paul Zappile, J. Nakitandwe, C. Ganzel, J. Dalton, D. Ellison, Juvianee I. Estrada-Veras, M. Lacouture, W. Gahl, P. Stephens, V. Miller, J. Ross, Siraj M. Ali, S. Briggs, O. Fasan, Jared G Block, S. Héritier, J. Donadieu, D. Solit, D. Hyman, J. Baselga, F. Janku, B. Taylor, Christopher Y. Park, Z. Amoura, A. Dogan, J. Emile, N. Rosen, T. Gruber, O. Abdel-Wahab 		8 2016
8
🐜
🐢 Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor.
11 auth. V. R. Belum, B. Benhuri, M. Postow, M. Hellmann, A. Lesokhin, N. Segal, ... R. Motzer, S. Wu, K. Busam, J. Wolchok, M. Lacouture 		8 2016
8
🐢
🐢 Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.
T. Lynch, Edward S. Kim, B. Eaby, J. Garey, D. West, M. Lacouture 		8 2007
8
🐢